Leukemia risk from chlorination seen mixed

	Tweet

Long-term exposure to the by-products of chlorination in drinking water appears to raise the risk of one type of leukemia—chronic myeloid leukemia (CML)—but decrease the risk of chronic lymphoid leukemia (CLL) and other types, new research shows.

The findings, which appear in the American Journal of Epidemiology, are based on a population-based study comparing 686 leukemia cases and 3420 similar but unaffected “controls” for whom water quality information was available for 30 years or longer. The subjects were Canadian residents between 20 and 74 years of age.

Long-term exposure to the chlorination by-product triahalomethane at levels greater than 40 micrograms per liter raised the risk of CML by 72 percent, Dr. Patrick Levallois, from Institut National de Sante Publique in Sainte-Foy, Canada, and colleagues note.

By contrast, such long-term exposure cut the risk of CLL by 40 percent, the team found.

Further analysis showed a decreased risk of several leukemia subtypes as the duration of chlorination by-product exposure increased, the report indicates.

“Total trihalomethanes and bromodichloromethane may be particularly important in the etiology of CML, but the possible protective effect of chlorination disinfection by-products on CLL remains unclear,” the authors conclude. “Random error or selection bias could explain these results,” they say.

SOURCE: American Journal of Epidemiology, January 15, 2006.

RELATED STORIES:
Towards more effective treatment for multiple myeloma   A New Way to Build Bone   Creating New Life Forms That May Help Eradicate Cancer Affecting Women   Pesticides raise child risk of leukaemia   Children with bone cancer at risk for second cancer   Whites at greatest risk for rare bone cancer   Drug Used for Advanced Cancer Could Cause Exposed Bone in Jaw   Bone loss seen in kids after stem cell therapy   Researchers Identify Potential Therapeutic Target in Osteosarcoma   Immune-Based Drug Approved in Europe for Pediatric Cancer Patients   U of M researchers look to dogs to better understand intricacies of bone cancer   Several factors affect bone marrow volume reduction   Going out on a limb   Study shows benefit of new maintenance therapy for multiple myeloma   New study shows positive role physical therapists play in lymphedema diagnois and treatment   Researchers Explore Issues Related to Multiple Myeloma Treatment   Backyard Garden May Yield Leukemia Treatment   Yeast unravels effects of chemotherapy drugs   Oral Drug Sets New Survival Standard for Bone Marrow Cancer   Approved lymphoma drug shows promise in early tests against bone cancer   Injured Marines at risk for abnormal bone growth   New Hope for Deadly Childhood Bone Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]